Kiora Pharmaceuticals Stock Market Value
| KPRX Stock | USD 2.08 0.06 2.80% |
| Symbol | Kiora |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiora Pharmaceuticals. Expected growth trajectory for Kiora significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Kiora Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Kiora Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Kiora's accounting equity. The concept of intrinsic value - what Kiora Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Kiora Pharmaceuticals' price substantially above or below its fundamental value.
Understanding that Kiora Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Kiora Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Kiora Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Kiora Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kiora Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kiora Pharmaceuticals.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Kiora Pharmaceuticals on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Kiora Pharmaceuticals or generate 0.0% return on investment in Kiora Pharmaceuticals over 90 days. Kiora Pharmaceuticals is related to or competes with Aprea Therapeutics, Biocardia, Acurx Pharmaceuticals, In8bio, Creative Medical, Aptevo Therapeutics, and HCW Biologics. Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies fo... More
Kiora Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kiora Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kiora Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 16.69 | |||
| Value At Risk | (5.19) | |||
| Potential Upside | 4.44 |
Kiora Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kiora Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kiora Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Kiora Pharmaceuticals historical prices to predict the future Kiora Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.37) | |||
| Treynor Ratio | (0.12) |
Kiora Pharmaceuticals February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 2.56 | |||
| Coefficient Of Variation | (2,739) | |||
| Standard Deviation | 3.27 | |||
| Variance | 10.71 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.37) | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 16.69 | |||
| Value At Risk | (5.19) | |||
| Potential Upside | 4.44 | |||
| Skewness | 0.5281 | |||
| Kurtosis | 1.2 |
Kiora Pharmaceuticals Backtested Returns
At this stage we consider Kiora Stock to be moderately volatile. Kiora Pharmaceuticals has Sharpe Ratio of 0.0574, which conveys that the firm had a 0.0574 % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Kiora Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Kiora Pharmaceuticals' Standard Deviation of 3.27, risk adjusted performance of (0.02), and Mean Deviation of 2.56 to check out if the risk estimate we provide is consistent with the expected return of 0.18%. Kiora Pharmaceuticals has a performance score of 4 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 1.11, which conveys a somewhat significant risk relative to the market. Kiora Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Kiora Pharmaceuticals is expected to follow. Kiora Pharmaceuticals right now secures a risk of 3.19%. Please verify Kiora Pharmaceuticals total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if Kiora Pharmaceuticals will be following its current price movements.
Auto-correlation | 0.09 |
Virtually no predictability
Kiora Pharmaceuticals has virtually no predictability. Overlapping area represents the amount of predictability between Kiora Pharmaceuticals time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kiora Pharmaceuticals price movement. The serial correlation of 0.09 indicates that less than 9.0% of current Kiora Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | -0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Kiora Stock Analysis
When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.